IRCT20181128041780N1 IRCT 2019-06-30 Mashhad University of Medical Sciences Effect of SLN containing finasteride on anderogenic alopecia Comparison of the effectiveness of SLN containing finasteride and finasteride tablets in androgenic alopecia 2018-11-30 anticipated 50 Complete https://irct.ir/trial/35839 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomized random numbered table, Blinding description: Drug administration and drug evaluation are performed by two different individuals, so that the person evaluating is not aware of which patient is in the group. 2-3 anderogenic alopecia. Intervention 1: Intervention group: In the first group, 5% localized minoxidil twice a day, any time 1 cc with a 0.1% finasteride topical form, as SLN, once a day, any time 1 cc. Intervention 2: Control group: The topical solution of minoxidil 5% is given twice daily, any time 1 cc, with one tablet of finasteride 1 mg per day. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The main researcher intends to produce the product. For this reason this data will remain confidential until Food and Drug Administration (FDA) needs it for documentation.